-
1 Comment
From a valuation standpoint, the stock is 96.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.0.
Based on the above factors, Simcere Pharmaceutical Group Limited gets an overall score of 1/5.
| Exchange | HK |
|---|---|
| ISIN | HK0000658531 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| CurrencyCode | HKD |
| Target Price | 9.9366 |
|---|---|
| Market Cap | 21B |
| PE Ratio | 26.94 |
| Dividend Yield | 2.1% |
| Beta | 0.45 |
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN, simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company has a strategic regional licensing partnership with Vivoryon Therapeutics N.V. to develop and commercialize SIM0801 and other drugs in the Greater China region, and a licensing and collaboration agreement with Guangzhou Fermion Technology Co., Ltd. to develop FZ002-037, an oral SSTR4 agonist for pain treatment. Simcere Pharmaceutical Group Limited was founded in 1995 and is headquartered in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2096.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
